Tiny Supercomputer Investment Company
Backing great companies when they’re tiny
TLV Partners
Israeli early-stage VC backing founders from seed and beyond
TMC Venture Fund
Venture capital arm of Texas Medical Center Corporation. $75M evergreen fund backing early-stage digital health, medical devices, and therapeutics companies.
TMV
NYC female-founded VC investing pre-seed to Series A with a "triple bottom line" philosophy, backing AI, healthcare, and logistics startups.
Transform VC
San Francisco deep-tech VC backing overlooked, underrepresented founders solving climate and social challenges through Seed and Series A investing.
Transformation Capital
Growth-stage digital health investor exclusively backing companies transforming care delivery, health data, behavioral health, and pharma with technology.
Transpose Platform Management
Global formation-stage VC and fund-of-funds backing early founders and emerging managers across sectors and geographies
Treeo VC
Fund by and for Turkish/immigrant founders, offering LPs a structured bridge into the U.S. AI-native startup ecosystem rather than just capital.
Trentino Invest
Rovereto, Italy public-private venture fund investing in R&D-intensive Trento-province startups across biotech, clean tech, and agri-food.
Triatomic Capital
Multi-stage deep tech and AI VC investing across next-gen compute, engineered biology, new materials, energy, and automation.
Tribe Capital
Harnessing AI & data science for precision investments in N-of-1 companies
True Ventures
Human-centric early-stage VC backing bold founders
Tsinghua Capital
Beijing-based growth equity PE fund originating from Tsinghua University, backing hard-tech SMEs in advanced manufacturing, next-gen tech, and healthcare across China.
TSV Capital
Silicon Valley seed-stage firm backing technical immigrant founders in AI, robotics, advanced manufacturing, and energy, with 200+ investments including Zoom and Carta.
TT49
Munich-based VC backing German deep-tech spin-offs from research institutions like Fraunhofer, DLR, and Max-Planck.
TTGG Ventures
25-year Chinese growth-stage VC where the GP personally commits 10% of each fund's capital, having taken 55 portfolio companies public.
Two Bear Capital
Early-stage VC investing in life sciences and technology startups, backing founders solving complex problems in biotech, cybersecurity, and AI.
UCB Ventures
UCB's evergreen corporate VC (2017) backs early-stage cell/gene therapy, RNA modulation and regenerative medicine startups beyond its core focus.
UCI Health Ventures
Corporate VC arm of UCI Health investing in early-stage healthcare innovators
UKI2S
UK national seed fund investing in deep tech and science spinouts across defence, fusion, space, and engineering biology.
UNC Health Ventures
Corporate VC arm of UNC Health System, giving health-tech portfolio companies direct access to its hospital network for clinical validation.
Unconventional Ventures
Pre-seed and seed fund backing diverse founders — women, people of color, immigrants, and LGBTQ+ building scalable impact tech companies across the Nordics and Europe.
Unruly Capital
European solo-GP early-stage fund backing frontier deeptech and climate founders with radical or non-consensus ideas.
Upfront Ventures
Early-stage venture firm backing founders building transformational companies
Showing 649–672 of 709 investors
Get the Complete BioTech Investor Database
709 investors · Stages · Sectors · Locations · CSV + Excel
Get all 709 investors →